- Home
- ADMA vs SOUN Comparison
ADMA vs SOUN Comparison
Compare ADMA & SOUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- SOUN
- Stock Information
- Founded
- ADMA 2004
- SOUN 2005
- Country
- ADMA United States
- SOUN United States
- Employees
- ADMA N/A
- SOUN N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- SOUN EDP Services
- Sector
- ADMA Health Care
- SOUN Technology
- Exchange
- ADMA Nasdaq
- SOUN Nasdaq
- Market Cap
- ADMA 5.1B
- SOUN 4.6B
- IPO Year
- ADMA N/A
- SOUN N/A
- Fundamental
- Price
- ADMA $17.80
- SOUN $12.56
- Analyst Decision
- ADMA Strong Buy
- SOUN Buy
- Analyst Count
- ADMA 3
- SOUN 6
- Target Price
- ADMA $27.67
- SOUN $13.33
- AVG Volume (30 Days)
- ADMA 3.3M
- SOUN 50.8M
- Earning Date
- ADMA 08-06-2025
- SOUN 08-07-2025
- Dividend Yield
- ADMA N/A
- SOUN N/A
- EPS Growth
- ADMA 469.09
- SOUN N/A
- EPS
- ADMA 0.85
- SOUN N/A
- Revenue
- ADMA $474,174,000.00
- SOUN $131,449,000.00
- Revenue This Year
- ADMA $21.11
- SOUN $92.14
- Revenue Next Year
- ADMA $25.97
- SOUN $27.02
- P/E Ratio
- ADMA $20.93
- SOUN N/A
- Revenue Growth
- ADMA 43.58
- SOUN 136.97
- 52 Week Low
- ADMA $13.50
- SOUN $4.33
- 52 Week High
- ADMA $25.67
- SOUN $24.98
- Technical
- Relative Strength Index (RSI)
- ADMA 51.09
- SOUN 48.59
- Support Level
- ADMA $16.93
- SOUN $15.48
- Resistance Level
- ADMA $17.90
- SOUN $17.08
- Average True Range (ATR)
- ADMA 0.86
- SOUN 1.13
- MACD
- ADMA 0.04
- SOUN -0.22
- Stochastic Oscillator
- ADMA 59.11
- SOUN 31.83
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About SOUN SoundHound AI Inc
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.